SREBF1 and fatty liver disease: To further investigate the bioactive components of M. integrifolia that alleviate hepatic steatosis, molecular docking was performed for the three most active compounds from in vitro experiments (1, 6, and 8) with the key regulatory factor of lipogenesis, SREBP-1c (Figure 6A–C).